Combination treatment with progesterone and vitamin D hormone may be more effective than monotherapy for nervous system injury and disease
Open accessThe DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Abstract
More than two decades of pre-clinical research and two recent clinical trials have shown that progesterone (PROG) and its metabolites exert beneficial effects after traumatic brain injury (TBI) through a number of metabolic and physiological pathways that can reduce damage in many different tissues and organ systems. Emerging data on 1,25-dihydroxyvitamin D3 (VDH), itself a steroid hormone, have begun to provide evidence that, like PROG, it too is neuroprotective, although some of its actions may involve different pathways. Both agents have high safety profiles, act on many different injury and pathological mechanisms, and are clinically relevant, easy to administer, and inexpensive. Furthermore, vitamin D deficiency is prevalent in a large segment of the population, especially the elderly and institutionalized, and can significantly affect recovery after CNS injury. The combination of PROG and VDH in pre-clinical and clinical studies is a novel and compelling approach to TBI treatment.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
RETRACTED: The anti-inflammatory activity of 1,25-dihydroxyvitamin D3 in macrophages
Cohen-Lahav, M., Douvdevani, A., Chaimovitz, C., & Shany, S. (2007) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2006.12.093 · Cited by 118
RetractedHolick, M. F. (2004) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/80.6.1678s · Cited by 3,198
Vitamin D deficiency: a worldwide problem with health consequences
Holick, M. F., & Chen, T. C. (2008) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/87.4.1080s · Cited by 2,689
1,25-Dihydroxyvitamin D3 is a negative endocrine regulator of the renin-angiotensin system
Li, Y. C., Kong, J., Wei, M., Chen, Z.-F., Liu, S. Q., & Cao, L.-P. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0215219 · Cited by 1,625
Distribution of the vitamin D receptor and 1α-hydroxylase in human brain
Eyles, D. W., Smith, S., Kinobe, R., Hewison, M., & McGrath, J. J. (2005) · Journal of Chemical Neuroanatomy · doi:10.1016/j.jchemneu.2004.08.006 · Cited by 1,444
Vitamin D: a millenium perspective
Holick, M. F. (2003) · Journal of Cellular Biochemistry · doi:10.1002/jcb.10338 · Cited by 1,319
Lips, P. (2006) · Progress in Biophysics and Molecular Biology · doi:10.1016/j.pbiomolbio.2006.02.016 · Cited by 1,173
A mechanism converting psychosocial stress into mononuclear cell activation
Bierhaus, A., Wolf, J., Andrassy, M., Rohleder, N., Humpert, P. M., Petrov, D., Ferstl, R., von Eynatten, M., Wendt, T., Rudofsky, G., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0438019100 · Cited by 927
Clinical trials in head injury
Narayan, R. K., Michel, M. E., Ansell, B., Baethmann, A., Biegon, A., Bracken, M. B., Bullock, M. R., Choi, S. C., Clifton, G. L., Contant, C. F., et al. (2002) · Journal of Neurotrauma · doi:10.1089/089771502753754037 · Cited by 913
New clues about vitamin D functions in the nervous system
Garcion, E., Wion-Barbot, N., Montero-Menei, C. N., Berger, F., & Wion, D. (2002) · Trends in Endocrinology & Metabolism · doi:10.1016/s1043-2760(01)00547-1 · Cited by 904
Keel, M., & Trentz, O. (2005) · Injury · doi:10.1016/j.injury.2004.12.037 · Cited by 885
Progesterone receptors: form and function in brain
Brinton, R. D., Thompson, R. F., Foy, M. R., Baudry, M., Wang, J., Finch, C. E., Morgan, T. E., Pike, C. J., Mack, W. J., Stanczyk, F. Z., et al. (2008) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2008.02.001 · Cited by 675
Pfeifer, M., Begerow, B., & Minne, H. W. (2002) · Osteoporosis International · doi:10.1007/s001980200012 · Cited by 521
Niemann-Pick type C disease involves disrupted neurosteroidogenesis and responds to allopregnanolone
Griffin, L. D., Gong, W., Verot, L., & Mellon, S. H. (2004) · Nature Medicine · doi:10.1038/nm1073 · Cited by 395 · cited 2×
“Recent evidence, however, suggests a much wider role for this compound, especially in its biologically active form, which includes modulation of the immune system [31,59,100,113,117,122,172], the renin-angiotensin system [227], development of cardiovascular disease [176,186], neuromuscular function [222], cell cycle c…”
BackgroundCalcium and vitamin D: skeletal and extraskeletal health
Khazai, N., Judd, S. E., & Tangpricha, V. (2008) · Current Rheumatology Reports · doi:10.1007/s11926-008-0020-y · Cited by 385
Brown, J., Bianco, J. I., McGrath, J. J., & Eyles, D. W. (2003) · Neuroscience Letters · doi:10.1016/s0304-3940(03)00303-3 · Cited by 377 · cited 8×
“N IH -PA Author M anuscript N IH -PA Author M anuscript N IH -PA Author M anuscript N IH -PA Author M anuscript N IH -PA Author M anuscript N IH -PA Author M anuscript Table 1 Neuroprotective mechanisms of PROG and VDH. MECHANISM PROGESTERONE VITAMIN D NEURONAL APOPTOSIS ↓ cytochrome c [239] ↓ cytochrome c [162] ↓ bad…”
BackgroundInfluentialWhich circulating level of 25-hydroxyvitamin D is appropriate?
Lips, P. (2004) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2004.03.040 · Cited by 347
Neveu, I., Naveilhan, P., Jehan, F., Baudet, C., Wion, D., De Luca, H. F., & Brachet, P. (1994) · Molecular Brain Research · doi:10.1016/0169-328x(94)90119-8 · Cited by 241
Madrigal, J. (2002) · Neuropsychopharmacology · doi:10.1016/s0893-133x(01)00292-5 · Cited by 232
Garcion, E., Sindji, L., Leblondel, G., Brachet, P., & Darcy, F. (1999) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1999.0730859.x · Cited by 213
Female sex steroids: effects upon microglial cell activation
Drew, P. D., & Chavis, J. A. (2000) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(00)00386-6 · Cited by 209 · cited 12×
“Thien R, Baier K, Pietschmann P, Peterlik M, Willheim M. Interactions of 1 alpha,25dihydroxyvitamin D3 with IL-12 and IL-4 on cytokine expression of human T lymphocytes.”
BackgroundInfluentialGuennoun, R., Fiddes, R. J., Gouézou, M., Lombès, M., & Baulieu, E.-E. (1995) · Molecular Brain Research · doi:10.1016/0169-328x(95)00016-l · Cited by 208
Robertson, C. L., Puskar, A., Hoffman, G. E., Murphy, A. Z., Saraswati, M., & Fiskum, G. (2006) · Experimental Neurology · doi:10.1016/j.expneurol.2005.09.014 · Cited by 152
Vitamin D and genomic stability
Chatterjee, M. (2001) · Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis · doi:10.1016/s0027-5107(01)00080-x · Cited by 134
Immunohistochemical labeling of androgen receptors in the brain of rat and monkey
Clancy, A. N., Bonsall, R. W., & Michael, R. P. (1992) · Life Sciences · doi:10.1016/0024-3205(92)90375-y · Cited by 130 · cited 1×
“This expression largely coincides with VDR and 1αOHase distribution in the rodent brain [24,74], and also strongly overlaps with the known distributions of receptors for androgens, glucocorticoids, estradiol, and PROG [46,81,137,224].”
BackgroundAnticonvulsant effects of 1,25-dihydroxyvitamin D in chemically induced seizures in mice
Kalueff, A. V., Minasyan, A., & Tuohimaa, P. (2005) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2005.06.022 · Cited by 94
The cell cycle as a therapeutic target for Alzheimer's disease
Neve, R. L., & McPhie, D. L. (2006) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2005.09.005 · Cited by 92
Combination therapies for traumatic brain injury: prospective considerations
Margulies, S. S., & Hicks, R. (2009) · Journal of Neurotrauma · doi:10.1089/neu.2008-0794 · Cited by 22
Cited by
Cui, C., Cui, J., Jin, F., Cui, Y., Li, R., Jiang, X., Tian, Y., Wang, K., Jiang, P., & Gao, J. (2017) · Cellular Physiology and Biochemistry · doi:10.1159/000479571 · Cited by 5,203
Vitamin D and Risk of Cognitive Decline in Elderly Persons
Llewellyn, D. J. (2010) · Archives of Internal Medicine · doi:10.1001/archinternmed.2010.173 · Cited by 459
Maternal serum vitamin D levels during pregnancy and offspring neurocognitive development
Whitehouse, A. J. O., Holt, B. J., Serralha, M., Holt, P. G., Kusel, M. M. H., & Hart, P. H. (2012) · Pediatrics · doi:10.1542/peds.2011-2644 · Cited by 259
Maternal vitamin D levels and the autism phenotype among offspring
Whitehouse, A. J. O., Holt, B. J., Serralha, M., Holt, P. G., Hart, P. H., & Kusel, M. M. H. (2013) · Journal of Autism and Developmental Disorders · doi:10.1007/s10803-012-1676-8 · Cited by 100
Pozzi, F., Aloe, L., Frajese, G., & Frajese, G. (2013) · Research in Endocrinology · doi:10.5171/2013.552758 · Cited by 18
Metadata
- Authors
- Cekic, M., Sayeed, I., & Stein, D. G.
- Venue
- Frontiers in Neuroendocrinology
- Publisher
- Elsevier BV
- Published
- 2009-07
- Volume
- 30
- Issue
- 2
- Pages
- 158-172
- ISSN
- 0091-3022 (ISSN-L)
- OpenAlex
- W2079277269
- Cited by
- 108
- References
- 28
- FWCI
- 6.00
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.